Skip to main content

Guided Therapeutics Inc

GTHP
Exchange
OTC
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0000924515

No open-market purchases or sales by Guided Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding GTHP, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding GTHP at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Guided Therapeutics Inc insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 5, 2025 (view filing)4:16 PM ETAug 297 daysLateImhoff John EDirector, 10% OwnerPPurchase+166.7K$0.18+$30.0K+0.9%19.5M after
Sep 5, 2025 (view filing)4:16 PM ETAug 297 daysLateImhoff John EDirector, 10% OwnerPPurchase+166.7K–––191.7K afterDerivative
Sep 5, 2025 (view filing)11:50 AM ETAug 297 daysLateJames Michael CDirectorPPurchase+27.8K$0.18+$5.00K+5.3%553.5K after
Sep 5, 2025 (view filing)11:50 AM ETAug 297 daysLateJames Michael CDirectorPPurchase+27.8K–––52.8K afterDerivative
Sep 5, 2025 (view filing)Aug 297 daysLateGrujic AlanDirectorPPurchase+152.1K––+9.1%1.82M after
Sep 5, 2025 (view filing)Aug 297 daysLateGrujic AlanDirectorPPurchase+152.1K–––177.1K afterDerivative
May 23, 2025 (view filing)2:16 PM ETMar 777 daysImhoff John EDirector, 10% OwnerPPurchasePreferred Series C Stock+286––New position286 afterAmended
May 23, 2025 (view filing)2:16 PM ETMar 1371 daysImhoff John EDirector, 10% OwnerPPurchasePreferred Series E Stock+150––+60.0%400 afterAmended
May 23, 2025 (view filing)2:16 PM ETMar 1866 daysImhoff John EDirector, 10% OwnerPPurchase+1.26M$0.10+$126.3K+7.6%18.0M afterAmended2 lots
May 23, 2025 (view filing)2:16 PM ETMar 1866 daysImhoff John EDirector, 10% OwnerPPurchase+1.26M–––1.26M afterAmendedDerivative2 lots

Top 10 13F holders, Q2 2026

The largest institutional positions in Guided Therapeutics Inc at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding GTHP in 13F filings for Q2 2026.